يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Hannah Plaschkes"', وقت الاستعلام: 0.39s تنقيح النتائج
  1. 1
    Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP

    المؤلفون: Graham P. Collins, Stephen Booth, Rebecca Oliver, Catherine Hildyard, William R. Wilson, Andrew McMillan, Paul Fields, Hannah Plaschkes, Julia Wolf, Mark Bishton, Jaimal Kothari, Christopher P. Fox, Amy A Kirkwood, Arief Gunawan, Chris Hatton, Nicolas Martinez-Calle, John F. Griffith, Toby A. Eyre

    المصدر: Blood Adv

    مصطلحات موضوعية: medicine.medical_specialty, Vincristine, law.invention, 03 medical and health sciences, 0302 clinical medicine, International Prognostic Index, Randomized controlled trial, Prednisone, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Cyclophosphamide, Aged, Aged, 80 and over, Geriatrics, Lymphoid Neoplasia, Framingham Risk Score, business.industry, Hematology, Doxorubicin, 030220 oncology & carcinogenesis, Cohort, Rituximab, Lymphoma, Large B-Cell, Diffuse, Morbidity, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d89edaaccf84b785d529ffe4f6133dc
    https://doi.org/10.1182/bloodadvances.2021004286

    View record in OpenAIRE

    أضف إلى المفضلة
  2. 2
    Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity

    المؤلفون: Hannah Plaschkes, Graham P. Collins, Julia Wolf, Christopher P. Fox, Stephen Booth, Paul Fields, Arief Gunawan, Catherine Hildyard, Rebecca Oliver, Mark Bishton, Nicolas Martinez-Calle, Andrew McMillan, Amy A Kirkwood, Toby A. Eyre, Carolyn Mercer, Chris Hatton, John F. Griffith

    المصدر: British Journal of Haematology. 187:185-194

    مصطلحات موضوعية: Male, Vincristine, medicine.medical_specialty, Cyclophosphamide, Disease-Free Survival, Central Nervous System Neoplasms, 03 medical and health sciences, 0302 clinical medicine, International Prognostic Index, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Injections, Spinal, Aged, Aged, 80 and over, business.industry, Incidence (epidemiology), Hematology, medicine.disease, Lymphoma, Survival Rate, Methotrexate, Doxorubicin, 030220 oncology & carcinogenesis, Prednisolone, Prednisone, Female, Rituximab, Lymphoma, Large B-Cell, Diffuse, business, Follow-Up Studies, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8044d690e4f235054ea30d9d509a9ea9
    https://doi.org/10.1111/bjh.16070

    View record in OpenAIRE

    أضف إلى المفضلة
  3. 3
    Impact of intended and relative dose intensity of R‐CHOP in a large, consecutive cohort of elderly diffuse large B‐cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age

    المؤلفون: Andrew McMillan, Arief Gunawan, Graham P. Collins, Julia Wolf, Faouzi Djebbari, Mark Bishton, Stephen Booth, David W Eyre, Catherine Hildyard, Nicolas Martinez-Calle, Rebecca Oliver, Hannah Plaschkes, Paul Fields, Toby A. Eyre, Christopher P. Fox, Christian S. R. Hatton, John F. Griffith

    المصدر: Journal of Internal Medicine. 285:681-692

    مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Cyclophosphamide, Comorbidity, 030204 cardiovascular system & hematology, Cohort Studies, 03 medical and health sciences, Age Distribution, 0302 clinical medicine, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Internal Medicine, Humans, Medicine, Cumulative incidence, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Proportional hazards model, Incidence, Incidence (epidemiology), Age Factors, medicine.disease, Lymphoma, Treatment Outcome, 030104 developmental biology, Doxorubicin, Vincristine, Cohort, Prednisone, Female, Lymphoma, Large B-Cell, Diffuse, Rituximab, business, Diffuse large B-cell lymphoma, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4b5cf19b4aa01b03cab530bc51ded4
    https://doi.org/10.1111/joim.12889

    View record in OpenAIRE

    أضف إلى المفضلة
  4. 4
    Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma

    المؤلفون: Joanna M Oladipo, Hannah Plaschkes, Paul Fields, Arief Gunawan, Amy A Kirkwood, John Willan, Bing Tseu, Catherine Hildyard, Tim Ebsworth, Lucia Chen, Usman Khan, Robert Lown, Joe Browning, Adam Gibb, Patrick Horgan, Julia Wolf, Kim Linton, Jaimal Kothari, Dominic Gordon-Walker, Nimish Shah, Claire Higham, Graham P. Collins, Stephen Booth, Toby A. Eyre

    المصدر: Booth, S, Plaschkes, H, Kirkwood, A A, Gibb, A, Horgan, P, Higham, C, Oladipo, J M, Browning, J, Khan, U, Tseu, B, Chen, L, Willan, J, Wolf, J, Gunawan, A, Fields, P, Ebsworth, T, Lown, R, Gordon-Walker, D, Shah, N, Linton, K M, Collins, G P, Kothari, J, Hildyard, C & Eyre, T A 2020, ' Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma ', Blood Advances, vol. 4, no. 18, pp. 4337-4346 . https://doi.org/10.1182/BLOODADVANCES.2020002553
    Blood Adv

    مصطلحات موضوعية: medicine.medical_specialty, Vincristine/adverse effects, Osteoporosis, Cyclophosphamide/adverse effects, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Rituximab/adverse effects, medicine, Humans, Cyclophosphamide, Aged, Retrospective Studies, 030203 arthritis & rheumatology, Lymphoid Neoplasia, Manchester Cancer Research Centre, business.industry, Incidence (epidemiology), Antineoplastic Combined Chemotherapy Protocols/adverse effects, ResearchInstitutes_Networks_Beacons/mcrc, Retrospective cohort study, Hematology, medicine.disease, Osteopenia, Lymphoma, Large B-Cell, Diffuse/drug therapy, Doxorubicin, Vincristine, 030220 oncology & carcinogenesis, Rheumatoid arthritis, Prednisolone, Rituximab, Lymphoma, Large B-Cell, Diffuse, Doxorubicin/adverse effects, business, Diffuse large B-cell lymphoma, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc9701b57b526dc42a68d328f065ff7
    https://research.manchester.ac.uk/en/publications/eb959c06-89d1-46b1-aa0f-dda1a7688dd4

    View record in OpenAIRE

    أضف إلى المفضلة
  5. 5
    Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP

    المؤلفون: Graham P. Collins, Julia Wolf, Arief Gunawan, Hannah Plaschkes, Rebecca Oliver, Stephen Booth, Christopher P. Fox, Toby A. Eyre, Paul Fields, David W Eyre, Chris Hatton, Andrew McMillan, John F. Griffith, Catherine Hildyard, Nicolas Martinez-Calle, Mark Bishton

    المصدر: British journal of haematology. 186(4)

    مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, MEDLINE, Independent predictor, Sex Factors, Sex factors, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Cyclophosphamide, Male gender, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Incidence (epidemiology), Incidence, Hematology, medicine.disease, Prognosis, Lymphoma, Treatment Outcome, Doxorubicin, Vincristine, Cohort, Prednisone, Neoplasm staging, Female, Lymphoma, Large B-Cell, Diffuse, business, Rituximab

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cf157269be2d796bdcb9d4af28085a6
    https://pubmed.ncbi.nlm.nih.gov/31020646

    View record in OpenAIRE

    أضف إلى المفضلة
  6. 6
    Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

    المؤلفون: John Willan, Catherine Hildyard, Adam Gibb, Claire Higham, Arief Gunawan, Toby A. Eyre, Julia Wolf, Graham P. Collins, Joseph Andrew Browning, Patrick Horgan, Amy A Kirkwood, Joanna M Oladipo, Stephen Booth, Usman Khan, Paul Fields, Kim Linton, Jaimal Kothari, Hannah Plaschkes

    المصدر: Blood. 134:1615-1615

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Human immunodeficiency virus (HIV), Front line, Cell Biology, Hematology, medicine.disease_cause, medicine.disease, Biochemistry, Chemotherapy regimen, Older patients, Internal medicine, Compact bone, Medicine, business, Diffuse large B-cell lymphoma, Diagnostic radiologic examination

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f96ee6d92570fcb9afca3581a2dfb19c
    https://doi.org/10.1182/blood-2019-127374

    View record in OpenAIRE

    أضف إلى المفضلة
  7. 7
    CNS Relapse Risk in Consecutive R-CHOP/R-Mini-CHOP-Treated Elderly DLBCL Is Low, with High Risk Particularly Apparent in Those with CNS IPI 5-6 and/or Renal/Adrenal Involvement

    المؤلفون: Carolyn Mercer, Nicolas Martinez-Calle, Murali Kesavan, Graham P. Collins, Stephen Booth, Andrew McMillan, Catherine Hildyard, Faouzi Djebbari, Joseph Butler, Hannah Plaschkes, Mark Bishton, Christopher P. Fox, Amy A Kirkwood, Toby A. Eyre, Chris Hatton, John F. Griffith

    المصدر: Blood. 132:1694-1694

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Incidence (epidemiology), Immunology, Cell Biology, Hematology, CHOP, medicine.disease, Biochemistry, International Prognostic Index, Median follow-up, Internal medicine, medicine, Mucositis, Rituximab, Adverse effect, business, Progressive disease, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::280afbf2db074b98c6bfe8dae44a7e0f
    https://doi.org/10.1182/blood-2018-99-111010

    View record in OpenAIRE

    أضف إلى المفضلة
  8. 8
    Impact of Intended and Relative Dose Intensity of RCHOP in a Large, Consecutive Cohort of Elderly DLBCL Patients: No Difference in DFS for 70-80 Years Versus >80 Years and Idi Independently Predicts Survival

    المؤلفون: Mark Bishton, Jonathan Griffith, Julia Wolf, Chris Hatton, Catherine Hildyard, Graham P. Collins, Hannah Plaschkes, Nicolas Martinez-Calle, Christopher P. Fox, Andrew McMillan, Toby A. Eyre, David W Eyre

    المصدر: Blood. 132:573-573

    مصطلحات موضوعية: medicine.medical_specialty, Proportional hazards model, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Confidence interval, 03 medical and health sciences, 0302 clinical medicine, International Prognostic Index, B symptoms, Median follow-up, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, medicine.symptom, business, Diffuse large B-cell lymphoma, Progressive disease, 030215 immunology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::33b87d294b42c873198f862b9387324c
    https://doi.org/10.1182/blood-2018-99-110330

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء